| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research &Development | Director
3 companies
Malik Fady Ibraham is an EVP Research &Development at CYTOKINETICS INC with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $12.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $43.58 | $87,160.00 | -1.4% | -22.0% | +43.7% | |
| Mar 17, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 4,389 | $44.38 | $194,783.82 | -4.2% | -24.8% | +38.3% | |
| Mar 6, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 8,228 | $43.27 | $356,025.56 | -7.2% | -25.1% | +39.6% | |
| Mar 4, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $42.50 | $85,000.00 | -1.7% | -28.6% | +42.5% | |
| Mar 3, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,449 | $42.88 | $105,013.12 | -2.1% | -27.2% | +41.5% | |
| Feb 18, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $45.98 | $91,960.00 | -1.7% | -32.3% | +47.6% | |
| Feb 4, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $48.06 | $96,120.00 | -1.7% | -25.5% | +29.1% | |
| Jan 21, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $45.92 | $91,840.00 | -1.7% | -17.2% | +37.6% | |
| Jan 7, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $49.32 | $98,640.00 | -1.7% | -25.8% | +34.9% | |
| Dec 10, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $50.64 | $369,639.00 | -3.0% | -14.3% | +19.3% |